Orexo AB (publ) (STO:ORX)
Sweden · Delayed Price · Currency is SEK 29.80
-0.25 (-0.84%)
Feb 10, 2026, 5:29 PM CET
Orexo AB Market Cap
Orexo AB has a market cap or net worth of 1.03 billion as of February 10, 2026. Its market cap has increased by 52.04% in one year.
Market Cap
1.03B
Enterprise Value
607.36M
Revenue
26.00M
Ranking
n/a
PE Ratio
1.61
Stock Price
29.80
Market Cap Chart
Since November 9, 2005, Orexo AB's market cap has increased from 861.50M to 1.03B, an increase of 19.36%. That is a compound annual growth rate of 0.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 1.03B | -1.00% |
| Dec 30, 2025 | 1.04B | 72.00% |
| Dec 30, 2024 | 603.84M | 13.47% |
| Dec 29, 2023 | 532.14M | -17.90% |
| Dec 30, 2022 | 648.17M | -45.27% |
| Dec 30, 2021 | 1.18B | -30.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.05B |
| Cereno Scientific AB | 2.10B |
| EQL Pharma AB | 1.82B |
| Cinclus Pharma Holding AB | 784.63M |
| Dicot Pharma AB | 661.07M |
| Nanexa AB | 592.66M |
| Enzymatica AB | 449.06M |
| Moberg Pharma AB | 430.29M |